Accropeutics

Developer of drugs for inflammation, autoimmune diseases, and cancer

placeSuzhou, Jiangsu, China calendar_todayFounded 2017 language accropeutics.com

Social engagement

Social engagement: 131 social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Shenzhen Capital Group, Orbimed.

Investor typeCountShare
Venture capital9100%

Recent activity

15 Sep 2025
Event
EADV 2025
4 Sep 2025
Event
EADV Congress 2025
Coming soon